4//SEC Filing
EAGLE PHARMACEUTICALS, INC. 4
Accession 0001209191-17-039190
CIK 0000827871operating
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:46 PM ET
Size
5.3 KB
Accession
0001209191-17-039190
Insider Transaction Report
Form 4
Meyers Peter A.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2017-06-12$71.49/sh+350$25,021→ 350 total
Footnotes (1)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $71.4414 to $71.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000827871
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:46 PM ET
- Size
- 5.3 KB